Dr Andrew J Holman MD

Dr Andrew J. Holman MD is an expert on Fibromyalgia Syndrome, who is leading the way into novel avenues of knowledge and treatment regarding the condition.

Dr Holman holds three concurrent positions as Chief Scientific Officer at Inmedix, LLC; President and Clinical Rheumatologist at Pacific Rheumatology Associates and Pacific Rheumatology Research, Inc.; and Associate Clinical Professor of Medicine at the University of Washington. He received his baccalaureate magna cum laude with departmental honors in chemistry from Bowdoin College and his medical degree from the University of Missouri-Columbia. He served his internal medicine residency at Presbyterian-St. Luke’s Medical Center in Denver, and a rheumatology fellowship at the University of Washington in Seattle.

Dr Holman is a member of several professional organizations, including the American College of Rheumatology and the Northwest Rheumatism Society, for which he served as president in 2005. He has participated in numerous pharmacologic and nonpharmacologic trials studying the role of the autonomic nervous system in Fibromyalgia Syndrome, chronic widespread pain and autoimmune diseases. He was instrumental in the initial discovery and further development of treatment of Fibromyalgia Syndrome using dopamine agonists and published the first randomized, placebo-controlled trials of these agents, including ropinirole and pramipexole.

After 15 years of clinical practice focusing of Fibromyalgia Syndrome and rheumatoid arthritis, Dr Holman currently maintains a research practice to develop new diagnostic and treatment modalities. Recent research has included heart rate variability (HRV) assessment of autonomic tone to predict treatment response in inflammatory arthritis, exploration of obstructive sleep apnea as an important cardiovascular risk among patents with rheumatoid arthritis and lupus, as well as evaluating a new type of pain related to intermittent, positional cervical spinal cord compression commonly found among patients with Fibromyalgia Syndrome.

Return to the PAB page